Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

EPOGEN, NEUPOGEN SALES DRIVE AMGEN EARNINGS

Oct. 18, 1991

CAMBRIDGE BIO RAISES $25.6 MILLION

Oct. 18, 1991

IMMUNEX BEGINS SARCOMA TREATMENT TRIALS

Oct. 18, 1991

TRIALS OF GROWTH FACTOR IN EYE SURGERY

Oct. 18, 1991

BROAD PATENT ISSUED FOR CENTOXIN

Oct. 17, 1991

AIDS VACCINE SHOWS EARLY PROMISE

Oct. 17, 1991

CYTEL FILES FOR 2.5 MILLION-SHARE IPO

Oct. 17, 1991

SUNY/ENZO WIN ANTISENSE DISPUTE

Oct. 17, 1991

CIBA DIVISION ALLIANCE WITH INSITE

Oct. 17, 1991

GENENTECH'S t-PA SALES CONTINUE TO SLIDE

Oct. 17, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...